Patients who received hyperimmune plasma treatment in Uruguay recovered from their covid-19 infection in 89.6% of cases, ASSE reported Monday.
The survey, which collected data from 357 people, concluded that 320 of them managed to recover, while 30 died.
The plasma transfusion treatment, released by the National Emergency System in early April, when Uruguay was going through its first great pandemic wave and the majority of the population was not vaccinated, was applied mostly to people over 65 years of age during the first 72 hours of your illness. It began to be used in April 2020 and it became widespread this year to increase the immune response of those with more complex conditions.
Of the patients treated, 64% belonged to a private health provider while 36% were treated by the public system.
Last January, scientist Henry Cohen told radio Sarandí that the plasma technique in patients who had covid-19 can reduce severe cases in patients over 65 years of age by “more than 60%” if applied on the third day of course the disease.
– .
